FDA OKs Biologic Guselkumab (Tremfya) for Plaque Psoriasis FDA OKs Biologic Guselkumab (Tremfya) for Plaque Psoriasis

Guselkumab is the first and only approved biologic agent that selectively blocks interleukin-23, a key player in plaque psoriasis.FDA Approvals

Source: Medscape Medical News Headlines - July 14, 2017 Category: Consumer Health News Tags: Dermatology News Alert Source Type: news